-
1
-
-
10644222796
-
New aspects in the pathogenesis of diabetic atherothrombosis
-
Moreno PR, Fuster V. New aspects in the pathogenesis of diabetic atherothrombosis. J Am Coll Cardiol. 2004;44:2293-2300.
-
(2004)
J Am Coll Cardiol.
, vol.44
, pp. 2293-2300
-
-
Moreno, P.R.1
Fuster, V.2
-
2
-
-
0141615827
-
Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part i
-
Creager MA, Luscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation. 2003;108:1527-1532.
-
(2003)
Circulation.
, vol.108
, pp. 1527-1532
-
-
Creager, M.A.1
Luscher, T.F.2
Cosentino, F.3
Beckman, J.A.4
-
3
-
-
0032431072
-
Endothelial dysfunction in diabetes mellitus
-
Cosentino F, Luscher TF. Endothelial dysfunction in diabetes mellitus. J Cardiovasc Pharmacol. 1998;32(suppl 3):S54-S61.
-
(1998)
J Cardiovasc Pharmacol.
, vol.32
, Issue.SUPPL. 3
-
-
Cosentino, F.1
Luscher, T.F.2
-
4
-
-
12844253061
-
Endothelial function: Cardiac events
-
Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation. 2005;111:363-368.
-
(2005)
Circulation.
, vol.111
, pp. 363-368
-
-
Lerman, A.1
Zeiher, A.M.2
-
5
-
-
33645780634
-
Endothelial nitric oxide synthase in vascular disease: From marvel to menace
-
Forstermann U, Munzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation. 2006;113:1708-1714.
-
(2006)
Circulation.
, vol.113
, pp. 1708-1714
-
-
Forstermann, U.1
Munzel, T.2
-
6
-
-
42549088600
-
Endothelial arginase II: A novel target for the treatment of atherosclerosis
-
Ryoo S, Gupta G, Benjo A, Lim HK, Camara A, Sikka G, Sohi J, Santhanam L, Soucy K, Tuday E, Baraban E, Ilies M, Gerstenblith G, Nyhan D, Shoukas A, Christianson DW, Alp NJ, Champion HC, Huso D, Berkowitz DE. Endothelial arginase II: a novel target for the treatment of atherosclerosis. Circ Res. 2008;102:923-932.
-
(2008)
Circ Res.
, vol.102
, pp. 923-932
-
-
Ryoo, S.1
Gupta, G.2
Benjo, A.3
Lim, H.K.4
Camara, A.5
Sikka, G.6
Sohi, J.7
Santhanam, L.8
Soucy, K.9
Tuday, E.10
Baraban, E.11
Ilies, M.12
Gerstenblith, G.13
Nyhan, D.14
Shoukas, A.15
Christianson, D.W.16
Alp, N.J.17
Champion, H.C.18
Huso, D.19
Berkowitz, D.E.20
more..
-
7
-
-
72049107764
-
Arginase inhibition mediates cardioprotection during ischaemia- reperfusion
-
Jung C, Gonon AT, Sjoquist PO, Lundberg JO, Pernow J. Arginase inhibition mediates cardioprotection during ischaemia-reperfusion. Cardiovasc Res. 2010;85:147-154.
-
(2010)
Cardiovasc Res.
, vol.85
, pp. 147-154
-
-
Jung, C.1
Gonon, A.T.2
Sjoquist, P.O.3
Lundberg, J.O.4
Pernow, J.5
-
8
-
-
9644282852
-
Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles
-
Zhang C, Hein TW, Wang W, Miller MW, Fossum TW, McDonald MM, Humphrey JD, Kuo L. Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles. Hypertension. 2004;44:935-943.
-
(2004)
Hypertension.
, vol.44
, pp. 935-943
-
-
Zhang, C.1
Hein, T.W.2
Wang, W.3
Miller, M.W.4
Fossum, T.W.5
McDonald, M.M.6
Humphrey, J.D.7
Kuo, L.8
-
9
-
-
31944447852
-
Knockdown of arginase i restores no signaling in the vasculature of old rats
-
White AR, Ryoo S, Li D, Champion HC, Steppan J, Wang D, Nyhan D, Shoukas AA, Hare JM, Berkowitz DE. Knockdown of arginase I restores no signaling in the vasculature of old rats. Hypertension. 2006;47: 245-251.
-
(2006)
Hypertension.
, vol.47
, pp. 245-251
-
-
White, A.R.1
Ryoo, S.2
Li, D.3
Champion, H.C.4
Steppan, J.5
Wang, D.6
Nyhan, D.7
Shoukas, A.A.8
Hare, J.M.9
Berkowitz, D.E.10
-
10
-
-
79955150190
-
Arginase inhibition restores in vivo coronary microvascular function in type 2 diabetic rats
-
Grönros J, Jung C, Lundberg JO, Cerrato R, Ostenson CG, Pernow J. Arginase inhibition restores in vivo coronary microvascular function in type 2 diabetic rats. Am JPhysiol Heart Circ Physiol. 2011;300:H1174-H1181.
-
(2011)
Am JPhysiol Heart Circ Physiol.
, vol.300
-
-
Grönros, J.1
Jung, C.2
Lundberg, J.O.3
Cerrato, R.4
Ostenson, C.G.5
Pernow, J.6
-
11
-
-
37849019273
-
Diabetes-induced coronary vascular dysfunction involves increased arginase activity
-
Romero MJ, PlattDH, TawfikHE, Labazi M, El-Remessy AB, BartoliM, Caldwell RB, Caldwell RW. Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ Res. 2008;102:95-102.
-
(2008)
Circ Res.
, vol.102
, pp. 95-102
-
-
Romero, M.J.1
Tawfikhe, P.2
Labazi, M.3
El-Remessy, A.B.4
Bartoli, M.5
Caldwell, R.B.6
Caldwell, R.W.7
-
12
-
-
0034816774
-
Increased expression of arginase II in human diabetic corpus cavernosum: In diabetic-associated erectile dysfunction
-
Bivalacqua TJ, Hellstrom WJ, Kadowitz PJ, Champion HC. Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction. Biochem Biophys Res Commun. 2001;283:923-927.
-
(2001)
Biochem Biophys Res Commun.
, vol.283
, pp. 923-927
-
-
Bivalacqua, T.J.1
Hellstrom, W.J.2
Kadowitz, P.J.3
Champion, H.C.4
-
13
-
-
79955075627
-
Arginase 1 contributes to diminished coronary arteriolar dilation in patients with diabetes
-
Beleznai T, Feher A, Spielvogel D, Lansman SL, Bagi Z. Arginase 1 contributes to diminished coronary arteriolar dilation in patients with diabetes. Am J Physiol Heart Circ Physiol. 2011;300:H777-H783.
-
(2011)
Am J Physiol Heart Circ Physiol.
, vol.300
-
-
Beleznai, T.1
Feher, A.2
Spielvogel, D.3
Lansman, S.L.4
Bagi, Z.5
-
14
-
-
85047682553
-
Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: Reversal by ETA receptor blockade in patients with atherosclerosis
-
Böhm F, Ahlborg G, Pernow J. Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis. Clin Sci (Lond). 2002;102: 321-327.
-
(2002)
Clin Sci (Lond).
, vol.102
, pp. 321-327
-
-
Böhm, F.1
Ahlborg, G.2
Pernow, J.3
-
15
-
-
0034119983
-
Bradykinin-induced vasodilation of human forearm resistance vessels is primarily mediated by endothelium-dependent hyperpolarization
-
Honing ML, Smits P, Morrison PJ, Rabelink TJ. Bradykinin-induced vasodilation of human forearm resistance vessels is primarily mediated by endothelium-dependent hyperpolarization. Hypertension. 2000;35: 1314-1318.
-
(2000)
Hypertension.
, vol.35
, pp. 1314-1318
-
-
Honing, M.L.1
Smits, P.2
Morrison, P.J.3
Rabelink, T.J.4
-
16
-
-
0029121091
-
Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication
-
Stroes ES, Koomans HA, de Bruin TW, Rabelink TJ. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet. 1995;346:467-471.
-
(1995)
Lancet.
, vol.346
, pp. 467-471
-
-
Stroes, E.S.1
Koomans, H.A.2
De Bruin, T.W.3
Rabelink, T.J.4
-
17
-
-
33644816122
-
Quinapril treatment increases insulin-stimulated endothelial function and adiponectin gene expression in patients with type 2 diabetes
-
Hermann TS, Li W, Dominguez H, Ihlemann N, Rask-Madsen C, Major-Pedersen A, Nielsen DB, Hansen KW, Hawkins M, Kober L, Torp-Pedersen C. Quinapril treatment increases insulin-stimulated endothelial function and adiponectin gene expression in patients with type 2 diabetes. J Clin Endocrinol Metab. 2006;91:1001-1008.
-
(2006)
J Clin Endocrinol Metab.
, vol.91
, pp. 1001-1008
-
-
Hermann, T.S.1
Li, W.2
Dominguez, H.3
Ihlemann, N.4
Rask-Madsen, C.5
Major-Pedersen, A.6
Nielsen, D.B.7
Hansen, K.W.8
Hawkins, M.9
Kober, L.10
Torp-Pedersen, C.11
-
18
-
-
0030990857
-
The new a-amino acid N-hydroxy-nor-L-arginine: A high-affinity inhibitor of arginase well adapted to bind to its manganese cluster
-
Custot J, Moali C, Brollo M, Boucher JL, Delaforge M, Mansuy D, Tenu JP, Zimmermann JL. The new a-amino acid N-hydroxy-nor-L-arginine: a high-affinity inhibitor of arginase well adapted to bind to its manganese cluster. J Am Chem Soc. 1997;119:4086-4087.
-
(1997)
J Am Chem Soc.
, vol.119
, pp. 4086-4087
-
-
Custot, J.1
Moali, C.2
Brollo, M.3
Boucher, J.L.4
Delaforge, M.5
Mansuy, D.6
Tenu, J.P.7
Zimmermann, J.L.8
-
19
-
-
0035822618
-
Classical and slow-binding inhibitors of human type II arginase
-
Colleluori DM, Ash DE. Classical and slow-binding inhibitors of human type II arginase. Biochemistry (Mosc). 2001;40:9356-9362.
-
(2001)
Biochemistry (Mosc).
, vol.40
, pp. 9356-9362
-
-
Colleluori, D.M.1
Ash, D.E.2
-
20
-
-
33751400907
-
Radio-chemical HPLC detection of arginine metabolism: Measurement of nitric oxide synthesis and arginase activity in vascular tissue
-
De Bono JP, Warrick N, Bendall JK, Channon KM, Alp NJ. Radio-chemical HPLC detection of arginine metabolism: measurement of nitric oxide synthesis and arginase activity in vascular tissue. Nitric Oxide. 2007;16:1-9.
-
(2007)
Nitric Oxide.
, vol.16
, pp. 1-9
-
-
De Bono, J.P.1
Warrick, N.2
Bendall, J.K.3
Channon, K.M.4
Alp, N.J.5
-
22
-
-
34447528959
-
Arginase: A critical regulator of nitric oxide synthesis and vascular function
-
Durante W, Johnson FK, Johnson RA. Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol. 2007;34:906-911.
-
(2007)
Clin Exp Pharmacol Physiol.
, vol.34
, pp. 906-911
-
-
Durante, W.1
Johnson, F.K.2
Johnson, R.A.3
-
23
-
-
84255192664
-
Diabetes-induced vascular dysfunction involves arginase i
-
Romero MJ, Iddings JA, Platt DH, Ali MI, Cederbaum SD, Stepp DW, Caldwell RB, Caldwell RW. Diabetes-induced vascular dysfunction involves arginase I. Am J Physiol Heart Circ Physiol. 2011;302: H159-H166.
-
(2011)
Am J Physiol Heart Circ Physiol.
, vol.302
-
-
Romero, M.J.1
Iddings, J.A.2
Platt, D.H.3
Ali, M.I.4
Cederbaum, S.D.5
Stepp, D.W.6
Caldwell, R.B.7
Caldwell, R.W.8
-
24
-
-
80755152815
-
Arginase-2 mediates diabetic renal injury
-
Morris SM, Jr., Gao T, Cooper TK, Kepka-Lenhart D, Awad AS. Arginase-2 mediates diabetic renal injury. Diabetes. 2011;60:3015-3022.
-
(2011)
Diabetes.
, vol.60
, pp. 3015-3022
-
-
Morris Jr., S.M.1
Gao, T.2
Cooper, T.K.3
Kepka-Lenhart, D.4
Awad, A.S.5
-
25
-
-
84864050457
-
Selective endothelial overexpression of arginase II induces endothelial dysfunction and hypertension and enhances atherosclerosis in mice
-
Vaisman BL, Andrews KL, Khong SML, Wood KC, Moore XL, Fu Y, Kepka-Lenhart DM, Morris SM, Jr., Remaley AT, Chin-Dusting JPF. Selective endothelial overexpression of arginase II induces endothelial dysfunction and hypertension and enhances atherosclerosis in mice. PLoS ONE. 2012;7:e39487.
-
(2012)
PLoS ONE.
, vol.7
-
-
Vaisman, B.L.1
Andrews, K.L.2
Sml, K.3
Wood, K.C.4
Moore, X.L.5
Fu, Y.6
Kepka-Lenhart, D.M.7
Morris Jr., S.M.8
Remaley, A.T.9
Chin-Dusting, J.P.F.10
-
26
-
-
38149109904
-
Insulin reduces plasma arginase activity in type 2 diabetic patients
-
Kashyap SR, Lara A, Zhang R, Park YM, DeFronzo RA. Insulin reduces plasma arginase activity in type 2 diabetic patients. Diabetes Care. 2008;31:134-139.
-
(2008)
Diabetes Care.
, vol.31
, pp. 134-139
-
-
Kashyap, S.R.1
Lara, A.2
Zhang, R.3
Park, Y.M.4
Defronzo, R.A.5
-
27
-
-
0035743353
-
Insulin action in the vasculature: Physiology and pathophysiology
-
Mather K, Anderson TJ, Verma S. Insulin action in the vasculature: physiology and pathophysiology. J Vasc Res. 2001;38:415-422.
-
(2001)
J Vasc Res.
, vol.38
, pp. 415-422
-
-
Mather, K.1
Anderson, T.J.2
Verma, S.3
-
28
-
-
34447639114
-
Endothelial dysfunction in insulin resistance and type 2 diabetes
-
Jansson PA. Endothelial dysfunction in insulin resistance and type 2 diabetes. J Intern Med. 2007;262:173-183.
-
(2007)
J Intern Med.
, vol.262
, pp. 173-183
-
-
Jansson, P.A.1
-
29
-
-
33745685243
-
Enhanced endothelium-dependent vasodilatation by dual endothelin receptor blockade in individuals with insulin resistance
-
Shemyakin A, Böhm F, Wagner H, Efendic S, Bavenholm P, Pernow J. Enhanced endothelium-dependent vasodilatation by dual endothelin receptor blockade in individuals with insulin resistance. J Cardiovasc Pharmacol. 2006;47:385-390.
-
(2006)
J Cardiovasc Pharmacol.
, vol.47
, pp. 385-390
-
-
Shemyakin, A.1
Böhm, F.2
Wagner, H.3
Efendic, S.4
Bavenholm, P.5
Pernow, J.6
-
30
-
-
34249733810
-
Up-regulation of arginase activity contributes to attenuated reflex cutaneous vasodilatation in hypertensive humans
-
Holowatz LA, Kenney WL. Up-regulation of arginase activity contributes to attenuated reflex cutaneous vasodilatation in hypertensive humans. J Physiol. 2007;581:863-872.
-
(2007)
J Physiol.
, vol.581
, pp. 863-872
-
-
Holowatz, L.A.1
Kenney, W.L.2
-
31
-
-
79954564392
-
Oral atorvastatin therapy restores cutaneous microvascular function by decreasing arginase activity in hypercholesterolaemic humans
-
Holowatz LA, Santhanam L, Webb A, Berkowitz DE, Kenney WL. Oral atorvastatin therapy restores cutaneous microvascular function by decreasing arginase activity in hypercholesterolaemic humans. J Physiol. 2011;589:2093-2103.
-
(2011)
J Physiol.
, vol.589
, pp. 2093-2103
-
-
Holowatz, L.A.1
Santhanam, L.2
Webb, A.3
Berkowitz, D.E.4
Kenney, W.L.5
|